Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Q.N. Myrvik, E.S. leake, B. Fariss.
Studies on pulmonary alveolar macrophages from the normal rabbit. A technique to procure them in a high State of purity.
J Immunol, 86 (1961), pp. 128-132
[2.]
T.N. Finley, E.W. Swenson, W.S. Curran, G.L. Huber, A.J. Ladman.
Bronchopulmonary lavage in normal subjects and patients with obstructive lung diseases.
Ann Intern Med, 66 (1967), pp. 651-658
[3.]
D.O. Adams, T.A. Hamilton.
The cell biology of macrophage activation.
Ann Rev Immunol, 2 (1984), pp. 283-318
[4.]
M.Y. Gordon.
Adhesive properties of haemopoietic stem cells.
Br J Haematol, 68 (1988), pp. 149-151
[5.]
R.L. Silverstein, R.L. Nachman.
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion.
J Clin Invest, 79 (1987), pp. 867-874
[6.]
D.R. Phillips, I.F. Charo, L.V. Parise, L.A. Fitzgeral.
The platelet membrane glycoprotein IIb-IIIa complex.
Blood, 71 (1988), pp. 831-843
[7.]
J.F. Bohnsack, H.K. Kleinman, T. Takahashi, J.J. O'Sea, E.J. Brown.
Connective tissue proteins and phagocytic cell function.
Laminin enhances complement and Fc-mediated phagocytosis by cultured human macrophages. J Exp Med, 161 (1985),
[8.]
C.J. Parker, R.N. Frame, M.R. Elstad.
Vitronectin (S protein) augments the functional activity of monocyte receptor for IgG and complement C3b.
Blood, 71 (1988), pp. 86-93
[9.]
J.A. Marino, P.J. Spagnuolo.
Fibronectin and phagocytic clearance mechanisms.
J Lab Clin Med, 111 (1988), pp. 493-494
[10.]
V.M. Holers, T.G. Ruff, D.L. Parks, J.A. McDonald, L.L. Ballard, E.J. Brown.
Molecular cloning of a murine fibronectin receptor and its expression during inflammation.
Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J Exp Med, 169 (1989), pp. 1589-1605
[11.]
L.M. Shaw, A.M. Mercurio.
Interferon-gamma and lypopolysaccharide promote macrophage adherence to basement membrane glycoproteins.
J Exp Med, 1169 (1989), pp. 303-308
[12.]
E.J. Brown, J.L. Goodwin.
Fibronectin receptors of phagocytes.
Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes. J Exp Med, 167 (1988), pp. 777-793
[13.]
P.W. Modderman, A.E.G. Von der Borne, A. Sonnenberg.
VLA-2, VLA-5.
VLA-6 function as activation-independent platelet adhesion receptors for collagen, fibronectin and laminin respectively. Tissue Antigens, 33 (1989), pp. 357
[14.]
B. Villiger, D.G. Kelley, W. Engleman, C. Kuhn, J.A. McDonald.
Human alveolar macrophage fibronectin: synthesis secretion ultrastructural localization during gelatin-coated latex particle binding.
J. Cell Biol, 90 (1981), pp. 711-720
[15.]
H. Hand, A. Thori, J. Schlom, C.N. Rao, L. Liotta.
Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody.
Cancer Res, 45 (1985), pp. 2713-2719
[16.]
S. Bhakdi, R. Kaflein, T.S. Halstensen, F. Hugo, K.T. Preissner, T.E. Mollnes.
Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
Clin Exp Immunol, 74 (1988), pp. 459-464
[17.]
S.M. Nesbitt, I. Hart, M.A. Horton.
Epitope analysis of the vitronectin receptor α and ß chains.
Tissue Antigens, 33 (1989), pp. 357
[18.]
R.L.H. Bolhuis, P. Goedegebuure, D.M. Segal, S. Shaw, E. Braakman.
LFA-1 represents an adhesion molecule interacting with ICAM1.
Tissue Antigens, 33 (1989), pp. 253
[19.]
D.R. Freyer, M.L. Morganroth, C.E. Rogers, M.A. Arnaout, R.F. Todd.
Modulation of surface CD11/CD18 glycoproteins (Mol.
LFA-1, pl50,95) by human mononuclear phagocytes. Clin Immunol Immunopathol, 46 (1988), pp. 272-283
[20.]
S. Kouzan, R.D. Nolan, T. Fournier, J. Bignon, T.E. Eling, A.R. Brody.
Stimulation of arachidonic acid metabolism by adherence of alveolar macrophages to a plastic substrate.
Modulation by fetal bovine serum. Am Rev Respir Dis, 137 (1988), pp. 38-43
[21.]
C.M. Smith, D.P. Tukey, D. Mundshenk, et al.
Filtration deformability of rabbit pulmonary macrophage.
J Lab Clin Med, 99 (1982), pp. 568-579
[22.]
K.A. Brown, J. Ferrie, B. Wilbourn, D.C. Dumonde.
Benoxaprofen a potent inhibitor of monocyte/endothelial-cell interaction.
Lancet, 2 (1984), pp. 643
[23.]
D. Rimland, W.L. Hand.
The effect of ethanol on adherence and phagocytosis by rabbit alveolar macrophages.
J Lab Clin Med, 95 (1980), pp. 918-926
[24.]
R. Lomnitzer, A.R. Rabson, H.J. Koornhof.
The effects of cyclic AMP on leukocyte inhibitory factor production and on the inhibition of leukocyte migration.
Clin Exp Immunol, 24 (1976), pp. 42-48
[25.]
L.A. Boxer, J.M. Allen, A.M. Watanabe, et al.
Role of microtubules in granulocyte adherence.
Blood, 51 (1978), pp. 1045-1049
[26.]
R. McGregor, H. Friedman, E. Macarak, N. Kefalides.
Virus infection of endothelial cells increased granullocyte adherence.
J Clin Invest, 65 (1980), pp. 1469-1477
[27.]
C. Bowman, E. Butler, J. Repine.
Hyperoxia damages cultured endothedial cells causing increased neutrophil adherence.
Am Rev Respir Dis, 128 (1983), pp. 469-472
[29.]
U. Ryan, D. Schultz, J. Ryan.
Fc and C3 receptors on pulmonary endothelial cells.
Induction by injury. Science, 214 (1981), pp. 557-558
[30.]
V. Rossi, F. Breviario, P. Ghezzi, E. Dejana, A. Mantovani.
Prostacyclin synthesis induced in vascular cells by interleukin-1.
Science, 229 (1985), pp. 174-176
[31.]
M.P. Bevilacqua, J.S. Pobers, W. Majeau Fiers, R.S. Cotran, M.A. Gimbrone.
Recombinant tumor necrosis factor induced procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin-1.
Proc Natl Acad Sci USA, 83 (1986), pp. 4533-4537
[32.]
A.W. Boyd, I.P. Wicks, S.O. Wawrik, et al.
Functional studies on intercellular adhesions molecule-1 (ICAM-1).
Tissue Antigens, 33 (1989), pp. 279
[33.]
D.E. Doherty, C. Haslett, M.G. Tonnesen, P.M. Henson.
Human monocyte adherence: A primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
J Immunol, 138 (1987), pp. 1762-1771
[34.]
G. Endermann, A. Pronzcuk, G. Friedman, S. Lyndsey, L. Alderson, K.C. Hayes.
Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL.
Am J Pathol, 126 (1987), pp. 1-6
[35.]
R.B. Fick, E.S. Paul, W.W. Merrill, H.Y. Reynolds, J.S.O. Loke.
Alterations in the antibacterial properties of rabbit pulmonary macrophages exposed to wood smoke.
Am Rev Respir Dis, 129 (1984), pp. 76-81
[36.]
J.L. Pérez Castrillon, J.D. García Palomo, J.L. Pérez Arellano, A. Jiménez López.
Leukocyte chemotaxis.
Allergol et Immunopathol, 16 (1988), pp. 279-283
[37.]
R. Snyderman, M.C. Pike.
Chemoattractant receptors on phagocytic cells.
Ann Rev Immunol, 2 (1984), pp. 257-281
[38.]
M.R. Ruff, S.M. Wahl, C.B. Pert, P. Substance.
receptor-mediated chemotaxis of human monocytes.
Peptides, 6 (1985), pp. 107-111
[39.]
L.G. Miller, S. Nelson, W.R. Summer.
Benzodiacepine bindings sites on rat alveolar macrophages promote chemoluminiscence and chemotaxis.
Am Rev Respir Dis, 137 (1988), pp. A528
[40.]
I.M. Goldstein.
Chemotactic factor receptors on leukocytesscrantching the surface.
J Lab Clin Med, 97 (1981), pp. 599-601
[41.]
J. Moss, M. Vaughan.
Guanine nucleotide-binding proteins (G proteins) in activation of adenyl cyclase: Lessons learned from cholera and travelers diarrhea.
J Lab Clin Med, 113 (1989), pp. 258-268
[42.]
R.H. Michell.
How do receptors at the cell surface send signals to the cell interior.
Br Med J, 295 (1987), pp. 1320-1323
[43.]
R.H. Michell.
Post-receptor signalling pathways.
Lancet, 1 (1989), pp. 765-768
[44.]
T.P. Stossel.
The mechanical responses of white blood cells.
Inflammation: Basic principles and clinical correlates, pp. 325-342
[45.]
G. Poli, A. Erroi, N. Polentarutti, et al.
Defective chemotaxis of human alveolar macrophages.
Clin Immunol Immunopathol, 47 (1988), pp. 282-288
[47.]
G.A. Warr, R.R. Martin.
Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking.
Infect Immun, 9 (1974), pp. 769-771
[48.]
G.A. Warr, R.R. Mmartin.
In vitro migration of human alveolar macrophages.
Effects of cigarette smoking. Infect Immunol, 8 (1973), pp. 222-227
[49.]
G.B. Demarest, L.D. Hudson, L.C. Altman.
Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation.
Am Rev Respir Dis, 119 (1979), pp. 279-286
[50.]
C. Burgaleta, M.T. Moreno, J.L. de la Cruz.
Actividad funcional de los macrófagos alveolares en patología intersticial pulmonar.
Med Clin (Barc), 90 (1988), pp. 321-324
[51.]
E. Lemaire, P. Care, M.F. Legrand, et al.
Alveolar macrophage dysfunction in malignant lung tumours.
Thorax, 39 (1984), pp. 448-452
[52.]
R.A. Robbins, J.K. Rasmussen, M.E. Clayton, G.L. Gossman, T.J. Kendall, S.I. Rennard.
Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
J Lab Clin Med, 110 (1987), pp. 292-299
[53.]
G.P. Pasternack, R. Snyderman, M.C. Pike, R.J. Johnson, H.S. Shin.
Resistance of neoplasm to immunological destruction: role of a macrophage chemotaxis inhibitor.
J Exp Med, 149 (1978), pp. 93-102
[54.]
J. Muller-Quernheim, R.E. Schopf, P. Benes, V. Schultz, R. Ferlinz.
A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis.
Klin Wochenschr, 65 (1987), pp. 893-897
[55.]
J.E. Glasgow, B.E. Farrell, E.S. Fisher, D.A. Lauffenburger, R.P. Daniele.
The motile response of alveolar macrophages.
An experimental study using single cell and cell population approaches. Am Rev Respir Dis, 139 (1989), pp. 320-339
[56.]
R.N. Harada, J.E. Repine.
Pulmonary host defense mechanisms.
Chest, 87 (1985), pp. 247-252
[57.]
N.P. Christiansen, K.M. Skubitz.
Identification of the major lectin-binding surface proteins of human neutrophils and alveolar macrophages.
Blood, 71 (1988), pp. 1624-1632
[58.]
M. Kuhlman, K. Joiner, R.A.B. Ezekowitz.
The human mannosebinding protein functions as an opsonin.
J Exp Med, 169 (1989), pp. 173-1745
[59.]
A.B. Ezekowitz, L.E. Day, G.A. Herman.
A human mannosebinding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins.
J Exp Med, 167 (1988), pp. 1034-1046
[60.]
S.D. Wright, S.M. Levin, M.T.C. Jong, Z. Chad, L.G. Kabbash.
CD3(Cd l lb/CD18) expresses one bindings site for Arg-Gly-AspContaining peptides and a second site for bacterial lypopolysaccharide.
J Exp Med, 169 (1989), pp. 175-183
[61.]
H.M. Wolf, J.W. Mannhalter, H.C. Salzmann, J. Gottlicher, R. Ahmad, M.M. Eibl.
Phagocytosis of serum-opsonized symosan downregulares the expression of CR3 and FCRI in the membranes of human monocytes.
J Immunol, 141 (1988), pp. 3537-3543
[62.]
A. Ding, S.D. Weight, C. Nathan.
Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac 1 (Complement receptor type 3).
J Exp Med, 165 (1987), pp. 733-749
[63.]
B.I. Myones, J.G. Dalzell, N. Hogg, G.D. Ross.
Neutrophil and monocyte cell surface p 150,95 has iC3b-receptor (CR4) activity resembling CR3.
J Clin Invest, 82 (1988), pp. 640-651
[64.]
J.C. Unkeless.
Function and heterogeneity of human Fc receptors for immunoglobulin G.
J Clin Invest, 83 (1989), pp. 355-361
[65.]
S.B. Clarkson, P.A. Ory.
CD16. Developmentally regulated IgG Fe receptors on cultured human monocytes.
J Exp Med, 167 (1988), pp. 408-417
[66.]
E.J. Brown, A.M. Newell, H.D. Gresham.
Molecular regulation of phagocyte function.
Evidence for involvement of a guanosinetriphosphate-binding protein in opsonin-mediated phagocytosis by monocytes. J Immunol, 139 (1987), pp. 3777-3782
[67.]
S. Kouzan, J.E. Gallagher, T. Eling, A.R. Brody.
Binding of iron beads to sialic acid residues on macrophage membranes stimulates arachidonic acid metabolism.
Lab Invest, 53 (1985), pp. 320-327
[68.]
T.P. Stossel, J.H. Hartwig.
Interactions of actin, myosin, and a new actin-binding protein of rabbit pulmonary macrophages II.
Role in cytoplasmic movement and phagocytosis. J Cell Biol, 68 (1976), pp. 602-619
[69.]
J.H. Hartwig, W.A. Davies, T.P. Stossel.
Evidence for contractile protein translocation in macrophage spreading, phagocytosis, and phagolysosome formation.
J Cell Biol, 75 (1977), pp. 956-967
[70.]
P. D’Arcy Hart, M.R. Young, A.H. Gordon, K.H. Sullivan.
Inhibition of phagosome-lysosome fusion in macrophages by certain mycobacteria can be explained by inhibition of lysosomal movements observed after phagocytosis.
J Exp Med, 166 (1987), pp. 933-946
[71.]
R.J. Mason, T.P. Stossel, M. Vaughan.
Quantitative studies of phagocytosis by alveolar macrophages.
Biochem Biophys Acta, 304 (1973), pp. 864-870
[72.]
A.L. Esposito, L.A. Quinn, E.C. Lucey, G.L. Snider.
Effect of the elastase inhibitor.
Eglin-c on antibacterial mechanisms in experimental pneumonia. Description of a system to quantitative phagocytic and bactericidal activity of resident murine alveolar macrophages in vivo. Am Rev Respir Dis, 135 (1987), pp. 676-681
[73.]
S.J. Klebanoff.
Phagocytic cells: Products of oxygen memtabolism.
Inflammation. Basic principies and clinical correlates, pp. 391-444
[74.]
M.S. Cohen, B.E. Britigan, D.J. Hassett, G.M. Rosen.
Phagocytes.
O2 reduction and hydroxyl radical. Rev Infect Dis, 10 (1988), pp. 1088-1096
[75.]
A. Cantin, R. Begin.
Inorganic dust exposure enhances PMAstimulated alveolar macrophage superoxide release.
Am Rev Respir Dis, 135 (1987), pp. A346
[76.]
J.E. Craighead, B.T. Mossman.
The pathogenesis of asbestosassociated diseases.
N Engl J Med, 305 (1982), pp. 1446-1455
[77.]
E. Kagan, Y. Oghiso, D.P. Hartmann.
Enhanced release of a chemoattractant for alveolar macrophages after asbestos inhalation.
Am Rev Respir Dis, 128 (1983), pp. 680-687
[78.]
E.M. Lugano, J.H. Dauber, R.P. Daniele.
Acute experimental silicosis.
Lung morphology, histology and macrophage chemotaxin secretion. Am J Pathol, 109 (1982), pp. 27-36
[79.]
W.N. Rom, P.B. Bitterman, S.I. Rennard, A. Cantin, R.G. Crystal.
Characterization of the lower respiratory tract inflammation of non smoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts.
Am Rev Respir Dis, 136 (1987), pp. 1429-1434
[80.]
E. Goldstein, W. Lippert, D. Warhauer.
Pulmonary alveolar macrophage.
Defender against bacterial infection of the lung. J Clin Invest, 54 (1974), pp. 519-528
[81.]
S. Johnsson, D.M. Nusher, A. Chapman, A. Goree, E.C. Lawrence.
Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages.
J Infect Dis, 152 (1985), pp. 4-13
[82.]
S. Johnsson, D.M. Musher, E.C. Lawrence.
Phagocytosis and killing of Haemophilus influenzae by alveolar macrophages.
No difference between smokers and non-smokers. Eur J Respir Dis, 70 (1987), pp. 309-315
[83.]
G.M. Green, E.H. Kass.
The role of the alveolar macrophage in the clearance of bacteria from the lung.
J Exp Med, 119 (1964), pp. 167-175
[84.]
H.Y. Reynolds, J.A. Hazmierowski, H.H. Newball.
Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
J Clin Invest, 56 (1975), pp. 376-385
[85.]
T.F. Byrd, M.A. Horwitz.
Interferon gamma-activated human monocytes down-regulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophilia by limiting the availability of iron.
J Clin Invest, 83 (1989), pp. 1457-1465
[86.]
M. Kist, H. Koester, W. Bredt.
Mycoplasma pneumonia induced cytotoxic activity in guinea pig bronchoalveolar cell.
Am Rev Respir Dis, 131 (1985), pp. 869-874
[87.]
P.R.J. Gangadharam, P.F. Pratt.
In vitro response of murine alveolar and peritoneal macrophages to Mycobacterium intracellulare.
Am Rev Respir Dis, 128 (1983), pp. 1044-1047
[88.]
P.B. Weimberg, S. Becker, D.L. Granger, H.S. Koren.
Growth inhibition of Cryptococcus neoformans by human alveolar macrophages.
Am Rev Respir Dis, 136 (1987), pp. 1242-1247
[89.]
L. Beaman.
Fungicidal activation of murine macrophages by recombinant gamma interferon.
Infect Immun, 55 (1987), pp. 2951-2955
[90.]
E.J. Stott, M. Probert, L.H. Thomas.
Cytotoxicity of alveolar macrophages for virus-infected cells.
Nature, 255 (1975), pp. 710-712
[91.]
P.D. Walzer, M.E. Rutledge.
Humoral immunity in experimental Pneumocystis carinii infection.
J Lab Clin Med, 97 (1981), pp. 820-833
[92.]
J.M. Onofrio, G.B. Toews, M.F. Lipscomb, A.K. Pierce.
Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus.
Am Rev Respir Dis, 127 (1983), pp. 335-3341
[93.]
E. Brummer, D.A. Stevens.
Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.
Clin Exp Immunol, 70 (1987), pp. 520-528
[94.]
D.O. Adams, T.A. Hamilton.
Phagocytic cells: cytotoxic activities of macrophages.
Infflammation: Basic principies and clinical correlates, pp. 471-492
[95.]
P.C. Levy, R.J. Looney, N.J. Roberts, M.W. Frampton, D.H. Ryan, M.J. Utell.
Human alveolar macrophage antibody dependent cellularcytotoxicity (ADCC): Fc-gamma receptor I (FCRI) dependence and inhibition by human surfactant.
Am Rev Respir Dis, 137 (1988), pp. A39
[96.]
C. Bordignon, R. Avallone, G. Peri, N. Polentarutti, C. Mangioni, A. Mantovani.
Cytotoxicity on tumor cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
Clin Exp Immunol, 41 (1980), pp. 336-342
[97.]
J.C. Wissler, M.F. Lipscomb, V.M. Lem, G.B. Toews.
Tumor killing by human alveolar macrophages and blood monocytes.
Decreased cytotoxicity of human alveolar macrophages. Am Rev Respir Dis, 134 (1986), pp. 5332-5537
[98.]
S. Sone, S. Moriguchi, E. Shimizu, F. Ogushi, E. Tsubara.
In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin.
Cancer Res, 42 (1982), pp. 2227-2231
[99.]
P. LeMarbre, R. Vessella, J. Hoidal, J. Rinehart.
Human pulmonary macrophage tumor cell cytotoxicity.
Blood, 55 (1980), pp. 612-617
[100.]
W.B. Davis, E.R. Pacht, M. Spatafora, W.J. Martin.
Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers.
J Lab Clin Med, 111 (1988), pp. 293-298
[101.]
R.T. Perri, G. Vercellotti, J. McCarthy, R.L. Vessella, L.T. Furcht.
Laminin selectively enhances monocyte-macrophage tumoricidal activity.
J Lab Clin Med, 105 (1985), pp. 30-35
[102.]
D.B. Ettensohn, P.A. Lalor, N.J. Roberts.
Human alveolar macrophage suppression of lymphocyte proliferation.
Am Rev Respir Dis, 137 (1988), pp. 765-773
[103.]
P.G. Holt.
Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.
Clin Exp Immunol, 63 (1986), pp. 261-270
[104.]
G.W. Hunninghake.
Immunoregulatory functions of human alveolar macrophages.
Am Rev Respir Dis, 136 (1987), pp. 258-265
[105.]
H.B. Kaltreider, macrophages. Alveolar.
Enhancers or suppressors of pulmonary immune reactivity?.
Chest, 82 (1982), pp. 261-262
[106.]
E.A. Rich, D.J. Tweardy, H. Fugiwara, J.J. Ellner.
Spectrum of immunoregulatory functions and properties of human alveolar macrophages.
Am Rev Respir Dis, 136 (1987), pp. 258-265
[107.]
A. Lasser.
The mononuclear phagocytic system. A review.
Hum Pathol, 14 (1983), pp. 108-126
[108.]
Z.A. Ccohn.
The activation of mononuclear phagocytes: fact, fancy and future.
J Immunol, (1978), pp. 813-816
[109.]
W.P. Arend, M. Mannik.
The macrophage receptor for IgG: number and affinity for bindings sites.
J Immunol, 110 (1973), pp. 1455-1463
[110.]
J.D. Brain.
Lung macrophages.
How many kinds are there?. What do they do?. Am Rev Respir Dis, 137 (1988), pp. 507-509
[111.]
J.C. Weissler, R. Lyons, M.F. Lipscomb, G.B. Toews.
Human pulmonary macrophages.
Functional comparison of cells obtained from whole lung and by bronchoalveolar lavage. Am Rev Respir Dis, 133 (1986), pp. 437-477
[112.]
M.D. Rossman, S.D. Douglas.
The alveolar macrophage: Receptors and effector cell function.
Immunology and immunologic diseases of the lung, pp. 168-183
[113.]
A.B. Cohen, M.J. Cline.
The human alveolar macrophage: Isolation, cultivation in vitro, and studies of morphologic and functional characteristics.
J Clin Invest, 50 (1971), pp. 1390-1398
[114.]
P.E.G. Mann, A.B. Cohen, T.N. Finley, A.J. Ladman.
Alveolar macrophages. Structural and functional differences between nonsmokers and smokers of marijuana and tobacco.
Lab Invest, 25 (1971), pp. 111-120
[115.]
F. Jauvert, J. Bignon, P. Sebastien, P. Butez.
Stereological study of mononuclear alveolar cells collected by alveolar lavage in man.
Rev Fran Mal Resp, 2 (1974), pp. 18-27
[116.]
D. Sandron, H.Y. Reynolds, A.M. Laval, A. Venet, D. Israel--Biet, J. Chrétien.
Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients.
Cytological data in normals and sarcoid patients. Eur J Respir Dis, 68 (1986), pp. 177-185
[117.]
J.A. Elias, A.D. Schreiber, K. Gustilo, et al.
Differential inerleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes.
Relationship to cell maturity. J Immunol, 135 (1985), pp. 3198-3200
[118.]
V.A. Grant, A.S. Hamblin.
Human bronchoalveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis.
Clin Exp Immunol, 60 (1985), pp. 539-545
[119.]
J.A. Elias, M.D. Rossman, R.B. Zurier, R.P. Daniele.
Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin dependent process.
Am Rev Respir Dis, 131 (1985), pp. 94-99
[120.]
D. Sandron, H.Y. Reynoilds, A. Venet, A.M. Laval, D. Israel-Biet, J. Chrétien.
Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients: functional data in normal and sarcoid patients.
Eur J Respir Dis, 69 (1986), pp. 226-234
[121.]
T.J. Ferro, J.A. Kern, J.A. Elias, M. Kamoun, R.P. Daniele, M.D. Rossman.
Alveolar macrophages, blood monocytes and densityfractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen.
Am Rev Respir Dis, 135 (1987), pp. 682-687
[122.]
N. Clerici, S. Reboiras, C. Fierro, F. Leyva-Cobian.
Expression of la like (HLA-DR) antigens on human alveolar macrophages.
Clin Exp Immunol, 58 (1984), pp. 388-394
[123.]
A. Razma, J. Lynch, B. Wilson, P. Ward, S. Kunkel.
Expression of Ia-like (DR) antigen on human alveolar macrophages isolated by bronchoalveolar lavage.
Am Rev Respir Dis, 129 (1984), pp. 419-424
[124.]
U. Costabel, K.J. Bross, R. Andreesen, H. Mathys.
HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid.
Thorax, 41 (1986), pp. 261-265
[125.]
M.F. Lipscomb, C.R. Lyons, G. Nuñez, et al.
Human alveolar macrophages synthetise HLA-DR antigens in culture.
Am Rev. Respir Dis, 127 (1983), pp. A59
[126.]
J.S. Maron, L.C. Watters, T.E. King, R.J. Mason.
Alveolar macrophage HLA-DR expression is reduced in patients with idiopathic pulmonary fibrosis compared to healthy volunteers and correlates with T lymphocyte helper/suppreessor ratio.
Am Rev Respir Dis, 133 (1986), pp. A146
[127.]
D.A. Campbell, R.M. du Bois, R.G. Butcher, L.W. Poulter.
The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.
Clin Exp Immunol, 65 (1986), pp. 165-171
[128.]
D. Fertsch-Ruggio, D.R. Schoenberg, K. Vogel.
Induction of macrophage la antigen expression by rIFN-gamma and downregulation by IFN-alpha/beta and dexametasone are regulated transcriptionally.
J Immunol, 141 (1988), pp. 1582-1589
[129.]
L.A. Falk, L.M. Wahl, S.N. Vogel.
Analysis of la antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony stimulating factor or macrophage colony stimulating factor.
J Immunol, 140 (1988), pp. 2652-2660
[130.]
H.G. Fischer, S. Frosch, K. Reske, A.B. Reske-Kunz.
Granulocyte-macrophage colony-stimulating factors activates macrophage derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
J Immunol, 141 (1988), pp. 3882-3888
[131.]
T.J. Koerner, T.A. Hamilton, D.O. Adams.
Suppressed expression of surface la on macrophages by lipopolysaccharide: Evidence. for regulation at the level of accumulation of mRNA.
J Immunol, 139 (1987), pp. 239-243
[132.]
H.B. Kaltreider, P.K. Byrd, J.L. Curtis.
Expression of la by murine alveolar macrophages is up-regulated during the evolution of a specific immune response in pulmonary parenchyma.
Am Rev Respir Dis, 137 (1988), pp. 1411-1416
[133.]
M.F. Lipscomb, C.R. Lyons, G. Nuñez, et al.
Human alveolar macrophages: HLA-DR positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.
J Immunol, 136 (1986), pp. 497-504
[134.]
T.J. Ferro, D.S. Monos, B.T. Spear, et al.
Carbohydrate differences in HLA-DR molecules synthesized by alveolar macrophages and blood monocytes.
Am Rev Respir Dis, 135 (1987), pp. 1340-1344
[135.]
G.B. Toews, W.C. Vial, M.M. Dunn, M.F. Lipscomb.
Human alveolar macrophages produce interleukin-1.
Am Rev Respir Dis, 127 (1983), pp. A60
[136.]
M. Wewers, P. Bitterman, P. Pinkston, R.G. Crystal.
Human alveolar macrophages release much less interleukin-1 than human blood monocytes.
Am Rev Respir Dis, 127 (1983), pp. A59
[137.]
G.A. Koretzky, J.A. Elias, S.L. Kay, M.D. Rossman, P.C. Nowell, R.P. Daniele.
Spontaneous production of interleukin-1 by human alveolar macrophages.
Clin Immunol Immunopathol, 29 (1983), pp. 443-450
[138.]
S. Nagai, M. Takeuchi, K. Watanabe, H. Aung, T. Izumi.
Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects.
Chest, 94 (1988), pp. 694-700
[139.]
G.P. Brown, M. Monick, G.W. Hunninghake.
Interleukin-1 release is decreased from alveolar macrophages of smokers.
Am Rev Respir Dis, 137 (1988), pp. A88
[140.]
M.D. Wewers, C. Saltini, S. Sellers, et al.
Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 βgene.
Cell Immunol, 107 (1987), pp. 479-488
[141.]
G.W. Hunninghake.
Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
Am Rev Respir Dis, 129 (1984), pp. 569-572
[142.]
J.A. Kern, R.J. Lamb, J.C. Reed, J.A. Elias, R.P. Daniele.
Interleukin-1 beta gene expression in human monocytes and alveolar macrophages from normal subjects and patients with sarcoidosis.
Am Rev Respir Dis, 137 (1988), pp. 1180-1184
[143.]
Endres S, Ghorbani R, Lonnemann G, Van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin 1 ß from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor.
[144.]
S. Nagai, M. Takeuchi, T. Izumi.
The significance of IL-1 and the IL-1 inhibitory factor in the evaluation of inflammatory State in sarcoidosis and idiopathic pulmonary fibrosis.
Am Rev Respir Dis, 135 (1987), pp. A305
[145.]
P. Gosset, P. Lassalle, A.B. Tonnel, et al.
Production of an interleukin-1 inhibitory factor by human alveolar macrophages from normals and allergic asthmatic patients.
Am Rev Respir Dis, 138 (1988), pp. 40-46
[146.]
N.J. Roberts, A.H. Prill, T.N. Mann.
Interleukin-1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus.
J Exp Med, 163 (1986), pp. 511-519
[147.]
M. Monick, J. Glazier, G.W. Hunninghake.
Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.
Am Rev Respir Dis, 135 (1987), pp. 72-77
Copyright © 1990. Sociedad Española de Neumología y Cirugía Torácica
